Efficient and Accurate Screening Solutions for Drug Residues for Vaccines Treating Coccidiosis07 October 2015
UK - Coccidiosis is one of the most prevalent ubiquitous diseases worldwide that affects poultry.
It damages the gut wall causing decreased performance in bird growth and can lead to serious economic losses.
Coccidiosis vaccines and feed medications have traditionally been used to treat the disease with the aim to lessen the impact it has on intestinal damage and development of secondary bacterial disease.
Despite their advantages, residual levels of the antibiotic can remain in the tissue and as a result enter the human food chain.
This danger is recognised globally by the WHO and reinforced by EU and FDA dedicated regulations, laying out strict legislation for Maximum Residue Levels for veterinary drugs in meat and eggs.
This evokes the question, how can meat and eggs be screened efficiently, economically and accurately to ensure MRL’s are met?
Against traditional ELISA products, Randox Food supply Biochip Array Technology which allows simultaneous screening of multiple analytes from a single sample.
To put this into context, when using the Coccidiostat Biochip Array one biochip does the work of 12 ELISA's, providing major efficiencies. This multiplex screening method lessens the need for samples to be tested using expensive confirmatory methods like LC-MS.
Coccidiostat Array (EV3772)
The Randox Food Coccidiostat Array produces a quantitative result for all of the following 12 analytes: Lasalocid, Nicarbazin, Imidocarb, Toltrazuril, Maduramicin, Salnomycin, Clopidol, Monensin, Robenidine, Decoquinate, Halofuginone & Diclazuril.
Combining confidence with convenience Randox Food strive to combat laborious test methods with the aim to improve food safety.
ThePoultrySite News Desk